Reckitt Benckiser Group plc (OTCMKTS:RBGLY) Given Consensus Rating of “Buy” by Analysts

Reckitt Benckiser Group plc (OTCMKTS:RBGLY) has been assigned a consensus recommendation of “Buy” from the eight research firms that are presently covering the company, Marketbeat Ratings reports. Three analysts have rated the stock with a hold rating, two have assigned a buy rating and three have assigned a strong buy rating to the company.

A number of analysts have recently issued reports on the company. Royal Bank of Canada reiterated an “outperform” rating on shares of Reckitt Benckiser Group in a report on Friday, March 7th. Barclays cut shares of Reckitt Benckiser Group from an “overweight” rating to an “equal weight” rating in a research report on Tuesday, February 4th.

Reckitt Benckiser Group Stock Up 1.5 %

Reckitt Benckiser Group stock opened at $12.95 on Friday. The stock has a fifty day moving average price of $13.27 and a 200 day moving average price of $12.66. Reckitt Benckiser Group has a 52 week low of $10.24 and a 52 week high of $14.10. The company has a current ratio of 0.69, a quick ratio of 0.47 and a debt-to-equity ratio of 0.97.

Reckitt Benckiser Group Increases Dividend

The firm also recently declared a dividend, which will be paid on Thursday, June 5th. Stockholders of record on Friday, April 11th will be paid a $0.2909 dividend. This is a boost from Reckitt Benckiser Group’s previous dividend of $0.19. The ex-dividend date is Friday, April 11th.

Reckitt Benckiser Group Company Profile

Reckitt Benckiser Group plc manufactures and sells health, hygiene, and nutrition products worldwide. It offers acne treatment creams, facial washes, and cleansing pads; germ protection products; condoms; heartburn and indigestion solutions; joints health products; chest congestion, cough, and sinus remedies; brain health products; migraine-headaches and rheumatic pain products; sore throat medications; and hair removal products under the Airborne, Clearasil, Dettol, Durex, Gaviscon, Move Free, Neuriva, Nurofen, Mucinex, Strepsils, and Veet brands.